Home›Search›Cancer Nanotechnology

Cancer Nanotechnology

Springer Science + Business Media · United States · Est. 2007

ISSN1868-6958eISSN1868-6966

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.849

H-Indexi

SNIPi

0.742

Total Worksi

426

Total Citationsi

9,832

2yr Mean Citednessi

6.15

Open Impact Factor alternative

Aims & Scope

Journal information Electronic ISSN 1868-6966 Print ISSN 1868-6958 Abstracted and indexed in Baidu CLOCKSS CNKI CNPIEC Chemical Abstracts Service (CAS) Chinese Academy of Medical Science (CAMS) DOAJ Dimensions EBSCO EMBASE GoOA - The Chinese Academy of Sciences (CAS) Google Scholar INIS Atomindex Japanese Science and Technology Agency (JST) Naver OCLC WorldCat Discovery Service Ovid Discovery Portico ProQuest Reaxys SCImago SCOPUS Science Citation Index Expanded (SCIE) Semantic Scholar TD Net Discovery Service Wanfang eLibrary.ru © Springer-Verlag GmbH Austria, part of Springer Nature

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2007

Annual Volume~ 68 articles / year

StatusActive (last: 2026)

Total Publications426

Publisher OrgBioMed Central

OA Since2009

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoKoninklijke Bibliotheek; Library of Congress; National Science Library, Chinese Academy of SciencesCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

Springer Science + Business Media

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1868-6958 / 1868-6966

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, Koninklijke Bibliotheek; Library of Congress; National Science Library, Chinese Academy of Sciences, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

767

2019

472

2020

2021

745

2022

1.4k

2023

799

2024

359

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmaceutical ScienceQ1

Physical and Theoretical ChemistryQ1

Biomedical EngineeringQ2

OncologyQ2

Subject Classification

Web of Science Categories

Nanoscience & NanotechnologyOncology

Scopus Categories

Biomedical EngineeringPhysical and Theoretical ChemistryPharmaceutical ScienceOncology

Research Topics (OpenAlex)

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRNA Interference and Gene DeliveryGraphene and Nanomaterials ApplicationsAdvanced biosensing and bioanalysis techniquesRadiation Therapy and DosimetryNanoparticles: synthesis and applicationsAdvanced Nanomaterials in CatalysisExtracellular vesicles in diseaseMicroRNA in disease regulation

Frequently asked questions about Cancer Nanotechnology

Is Cancer Nanotechnology a predatory journal?

PubScope has no integrity flags on record for Cancer Nanotechnology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Nanotechnology?

Cancer Nanotechnology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.15.

Is Cancer Nanotechnology indexed in Scopus and Web of Science?

Cancer Nanotechnology is indexed in Web of Science, Scopus, DOAJ.